According to Pumen Technology's announcement, the company recently received the “People's Republic of China Medical Device Registration Certificate” issued by the Guangdong Drug Administration. The product name is Folic Acid Determination Kit, the registration classification is Class II, and the registration certificate number is Guangdong Device Note 20252401644, which is valid until December 18, 2030. This product is used to quantitatively measure folic acid content in human serum or plasma samples in vitro, and is clinically used as an auxiliary diagnosis of megaloblastic anemia. The folic acid test kit obtained this time is the company's next-generation product. Using sandwich chemiluminescence immunoassay, the sensitivity and precision of the reagents have been improved, which helps enhance the company's market competitiveness in the field of anemia testing. As of the announcement disclosure date, the company and its holding subsidiaries have obtained 106 registration certificates for electrochemiluminescence supporting test reagents, further enriching and improving the testing menu for the company's electrochemiluminescence reagent project and enhancing the company's market competitiveness in the field of immunodiagnosis. However, the actual sales situation after the product is launched depends on future market promotion effects, and it is currently impossible to predict the specific impact on the company's future performance.

According to Pumen Technology's announcement, the company recently received the “People's Republic of China Medical Device Registration Certificate” issued by the Guangdong Drug Administration. The product name is Folic Acid Determination Kit, the registration classification is Class II, and the registration certificate number is Guangdong Device Note 20252401644, which is valid until December 18, 2030. This product is used to quantitatively measure folic acid content in human serum or plasma samples in vitro, and is clinically used as an auxiliary diagnosis of megaloblastic anemia. The folic acid test kit obtained this time is the company's next-generation product. Using sandwich chemiluminescence immunoassay, the sensitivity and precision of the reagents have been improved, which helps enhance the company's market competitiveness in the field of anemia testing. As of the announcement disclosure date, the company and its holding subsidiaries have obtained 106 registration certificates for electrochemiluminescence supporting test reagents, further enriching and improving the testing menu for the company's electrochemiluminescence reagent project and enhancing the company's market competitiveness in the field of immunodiagnosis. However, the actual sales situation after the product is launched depends on future market promotion effects, and it is currently impossible to predict the specific impact on the company's future performance.